<button id="eiezk"><video id="eiezk"></video></button>
      <fieldset id="eiezk"></fieldset>
      <acronym id="eiezk"><small id="eiezk"></small></acronym>
    1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
      <acronym id="eiezk"><address id="eiezk"></address></acronym>
        <source id="eiezk"><pre id="eiezk"></pre></source>

        celvivo三維旋轉培養(yǎng)系統(tǒng)

        型號:
        聯(lián)系人:李勝亮
        聯(lián)系電話:18618101725
        品牌:celvivo



        3D Cell Culture Technology
        Mimicking In vivo Performance

        In vivo, cells in tissues and tumours do not double every 2 – 4 days as they do in classical (2D) cell culture – so why use a technology developed in the 1950's?

        The CelVivo system creates an environment which promotes the growth and maintenance of large 3D tissue mimetic structures, whether they are spheroids, organoids, acini and other aggregates.

        In this environment, liver spheroids remain in a stable dynamic equilibrium and exhibit human in vivo physiological performance for at least 24 days (i.e. up to at least 42 days of culture). During this time the spheroids exhibit a stable transcriptome profile.

        Reasons for Using 3D Cell Culture
        Why use 3D Spheroids


        CELL FEATURE Advantage over classical 2D cultures
        For HepG2-C3A - features for other cell lines maybe different
        Proliferation
        • Slows from a doubling time of 1 day to 60 days after 40 days in culture (see reference 3)
        • Resembles proliferation in the parental tissue or in tumours in vivo
        • Cultures can be maintained for over 300 days
        Architecture
        • Microfilaments (actin) microtubules (tubulin) and intermediate filaments (e.g. keratin) resemble that seen in vivo (see reference 7)
        Ultrastructure
        • Resembles liver sections, showing plasma membrane differentiation, tight junctions, bile canaliculus-like channels, lipid droplets and glycogen granules (see reference 2)
        Physiological performance
        Drug metabolism
        • Toxicity measurements for Amiodorone, APAP, Metformin, Phenformin and Valproic acid are more accurate than those obtained using human primary hepatocytes (see reference 1)
        Proteomics
        Metabolic reprogramming
        • > 21 day old spheroids show clear aerobic metabolism (Warburg effect) (see reference 7)
        Epigenetics
        • Spheroids display histone marks and clipping (not seen using 2D cultures) (see reference 9)
        Integration of cellular response
        • APAP causes protein oxidation and nitrosylation and this integrates the cellular response to physiological doses of APAP (see reference 11)

        Spheroid Characteristics

        Spheroids

        SPHEROIDS Characteristics
        For HepG2-C3A - values for other cell lines will be different
        Number of cells per spheroid (± 22%)
        • Day 8 = 23,156
        • Day 21 = 82,342
        • Media can be collected via one of the two ports
        Spheroid size
        (Planimetric surface)
        • Day 8 = 0.26 mm?
        • Day 21 = 0.58 mm?
        Protein concentration
        • Day 8 = 21.71 ?g/ mm?
        • Day 21 = 43.28 ?g/ mm?
        ATP concentration
        • Day 8 = 9.23 ?M/ mm?
        • Day 21 = 8.93 ?M/ mm?
        Bioreactor soluble protein content
        • Day 8 = 2,010 ?g
        • Day 21 = 10,120 ?g*
          * the culture will have been split into 4 bioreactors at this stage

        Bioreactor

        Bioreactor

        BIOREACTOR Advantages
        Easy access to samples and media
        • The bioreactor can be opened and closed again, providing a petri-dish like access to spheroids and media
        • Repeated sampling possible
        • Media can be collected via one of the two ports
        Multiple samples
        • Bioreactor can cultivate up to 300 mature identical 'biopsies' which can either be collected at once for multiple assays or at multiple time points for fewer assays
        Dynamic equilibrium
        • When non-lethal treatment stops, spheroids return to their resting state (dynamic equilibrium)
        Optimal growth environment
        • Rotating bioreactor- clinostat system
        • Inbuilt humidification chamber with good gas exchange
        • Inert materials used: non-toxic and low unspecific binding
        Use of different cell types
        • Cell from any species can be used
        • Primary-, stem- and immortal cells have to be used in clinostat systems
        • Co-culture of different cell types in the same bioreactor

        * The Bioreactor patent is owned by MC2 Biotec (MC2biotec.com). Celvivo is commercialising it on their behalf.

        BioArray Matrix Drive

         BioArray Matrix 
        Left (Video): Changing the growth media in the bioreactors and using the Bioarray matrix drive (BAM).
        Right: One of the 16 proprietary drive axel speed controllers.

        The drive's control board fits into a standard CO2 incubator (equipped with access port minimum of 24mm in diameter) and has 16 independently control drive axels which can rotate in either direction at speeds from 5 to 50 rpm. The system is temperature inert for the incubator. It can be controlled either from windows or android based devices.

        BIOARRAY MATRIX DRIVE Advantages
        Optimal growth environment for 3D culture
        • Rotating bioreactor- clinostat
        • Humidified chamber with good gas exchange
        • Inert materials used: non-toxic and low unspecific binding
        • Computer controlled multiple drive unit
        • Does not disturb incubator temperature
        Multiple bioreactors
        • 16 independent drives
        • 5-50 rpm in
        Easy control
        • Bioreactor rotation speed can be regulated from
          – a tablet (great for working in the cell culture lab)
          – a network computer
          – or smart phone (using the app provided)
        • Drives can be regulated independently or in any combination of groups
        Easy overview
        • Large simple display on tablet
        • Internal log
        Quick suspension option
        • Special start-up program to rapidly disperse spheroids after bioreactor has been stopped (e.g. for medium change or treatment)

        In vivo, cells in tissues and tumours do not double every 2 – 4 days as they do in classical (2D) cell culture – so why use a technology developed in the 1950's?

        The CelVivo system creates an environment which promotes the growth and maintenance of large 3D tissue mimetic structures, whether they are spheroids, organoids, acini and other aggregates.

        In this environment, liver spheroids remain in a stable dynamic equilibrium and exhibit human in vivo physiological performance for at least 24 days (i.e. up to at least 42 days of culture). During this time the spheroids exhibit a stable transcriptome profile.

        Reasons for Using 3D Cell Culture
        Why use 3D Spheroids


        CELL FEATURE Advantage over classical 2D cultures
        For HepG2-C3A - features for other cell lines maybe different
        Proliferation
        • Slows from a doubling time of 1 day to 60 days after 40 days in culture (see reference 3)
        • Resembles proliferation in the parental tissue or in tumours in vivo
        • Cultures can be maintained for over 300 days
        Architecture
        • Microfilaments (actin) microtubules (tubulin) and intermediate filaments (e.g. keratin) resemble that seen in vivo (see reference 7)
        Ultrastructure
        • Resembles liver sections, showing plasma membrane differentiation, tight junctions, bile canaliculus-like channels, lipid droplets and glycogen granules (see reference 2)
        Physiological performance
        Drug metabolism
        • Toxicity measurements for Amiodorone, APAP, Metformin, Phenformin and Valproic acid are more accurate than those obtained using human primary hepatocytes (see reference 1)
        Proteomics
        Metabolic reprogramming
        • > 21 day old spheroids show clear aerobic metabolism (Warburg effect) (see reference 7)
        Epigenetics
        • Spheroids display histone marks and clipping (not seen using 2D cultures) (see reference 9)
        Integration of cellular response
        • APAP causes protein oxidation and nitrosylation and this integrates the cellular response to physiological doses of APAP (see reference 11)

        Spheroid Characteristics

        Spheroids

        SPHEROIDS Characteristics
        For HepG2-C3A - values for other cell lines will be different
        Number of cells per spheroid (± 22%)
        • Day 8 = 23,156
        • Day 21 = 82,342
        • Media can be collected via one of the two ports
        Spheroid size
        (Planimetric surface)
        • Day 8 = 0.26 mm?
        • Day 21 = 0.58 mm?
        Protein concentration
        • Day 8 = 21.71 ?g/ mm?
        • Day 21 = 43.28 ?g/ mm?
        ATP concentration
        • Day 8 = 9.23 ?M/ mm?
        • Day 21 = 8.93 ?M/ mm?
        Bioreactor soluble protein content
        • Day 8 = 2,010 ?g
        • Day 21 = 10,120 ?g*
          * the culture will have been split into 4 bioreactors at this stage

        Bioreactor

        Bioreactor

        BIOREACTOR Advantages
        Easy access to samples and media
        • The bioreactor can be opened and closed again, providing a petri-dish like access to spheroids and media
        • Repeated sampling possible
        • Media can be collected via one of the two ports
        Multiple samples
        • Bioreactor can cultivate up to 300 mature identical 'biopsies' which can either be collected at once for multiple assays or at multiple time points for fewer assays
        Dynamic equilibrium
        • When non-lethal treatment stops, spheroids return to their resting state (dynamic equilibrium)
        Optimal growth environment
        • Rotating bioreactor- clinostat system
        • Inbuilt humidification chamber with good gas exchange
        • Inert materials used: non-toxic and low unspecific binding
        Use of different cell types
        • Cell from any species can be used
        • Primary-, stem- and immortal cells have to be used in clinostat systems
        • Co-culture of different cell types in the same bioreactor

        * The Bioreactor patent is owned by MC2 Biotec (MC2biotec.com). Celvivo is commercialising it on their behalf.

        BioArray Matrix Drive

         BioArray Matrix 
        Left (Video): Changing the growth media in the bioreactors and using the Bioarray matrix drive (BAM).
        Right: One of the 16 proprietary drive axel speed controllers.

        The drive's control board fits into a standard CO2 incubator (equipped with access port minimum of 24mm in diameter) and has 16 independently control drive axels which can rotate in either direction at speeds from 5 to 50 rpm. The system is temperature inert for the incubator. It can be controlled either from windows or android based devices.

        BIOARRAY MATRIX DRIVE Advantages
        Optimal growth environment for 3D culture
        • Rotating bioreactor- clinostat
        • Humidified chamber with good gas exchange
        • Inert materials used: non-toxic and low unspecific binding
        • Computer controlled multiple drive unit
        • Does not disturb incubator temperature
        Multiple bioreactors
        • 16 independent drives
        • 5-50 rpm in
        Easy control
        • Bioreactor rotation speed can be regulated from
          – a tablet (great for working in the cell culture lab)
          – a network computer
          – or smart phone (using the app provided)
        • Drives can be regulated independently or in any combination of groups
        Easy overview
        • Large simple display on tablet
        • Internal log
        Quick suspension option
        • Special start-up program to rapidly disperse spheroids after bioreactor has been stopped (e.g. for medium change or treatment)

        * The BAM is at the β-test version stage.



        Publications
        1. Metabolic Reprogramming and the Recovery of Physiological Functionality in 3D Cultures in Micro-Bioreactors
          Krzysztof Wrzesinski and Stephen J. Fey
          Bioengineering, 5 (2) 1-25: 2018
          http://www.mdpi.com/2306-5354/5/1/22 
          DOI: 10.3390/bioengineering5010022
          View Publication (PDF)
        2. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective.
          Carlemi Calitz, Josias H. Hamman, Stephen J. Fey, Krzysztof Wrzesinski & Chrisna Gouws
          Toxicology Mechanisms and Methods, 2018
          https://doi.org/10.1080/15376516.2017.1422580 
          DOI: 10.1080/15376516.2017.1422580
          View Publication (PDF)
        3. Acetaminophen-induced S-nitrosylation and S-sulfenylation signalling in 3D cultured hepatocarcinoma cell spheroids.
          K. Wojdyla, K. Wrzesinski, J. Williamson, P. Roepstorff, S.J. Fey, A. Rogowska-Wrzesinska 
          Toxicology Research 5(2) 905-920, 2016 
          http://xlink.rsc.org/?doi=c5tx00469a  
          DOI: 10.1039/C5TX00469A
          View Publication (PDF)
        4. From 2D to 3D - a new dimension for modelling the effect of natural products on human tissue. 
          K. Wrzesinski and S.J. Fey
          Current Pharmaceutical Design 21(38): 5605-5616, 2015. 
          PMID: 26429710 
          DOI: 10.2174/1381612821666151002114227
        5. Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped Human Histones Differ in Post-translational Modification Patterns. 
          A. Tvardovskiy, K. Wrzesinski, S. Sidoli, S.J. Fey, A. Rogowska-Wrzesinska, O.N. Jensen
          Molecular and Cellular Proteomics 14(12):3142-53; 2015. 
          PMID: 26424599 
          DOI: 10.1074/mcp.M115.048975
          Please write to [email protected] for a pdf copy of this publication
        6. The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments.
          K. Wrzesinski, A. Rogowska-Wrzesinska, R. Kanlaya, K. Borkowski, V. Schw?mmle, J. Daia, K.E. Joensen, K. Wojdyla, V. Botelho Carvalho & S.J. Fey 
          PLOS One 9(9) 1-15; 2014
          PMID: 25222612 
          DOI: 10.1371/journal.pone.0106973
          View Publication (PDF)
        7. The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments.
          K. Wrzesinski, A. Rogowska-Wrzesinska, K. Borkowski, V. Botelho Carvalho & S.J. Fey 
          Poster at 9th Danish Conference on Biotechnology and Molecular Biology, Vejle; 2014 
          DOI: 10.13140/2.1.2643.2965
        8. Heteromer s – using internal standards to assess the quality of proteomic data.
          A. Rogowska-Wrzesinska, K. Wrzesinski and S.J. Fey
          Proteomics. 14(9):1042-7 2014
          PMID: 24616253 
          DOI: 10.1002/pmic.201300457
          Please write to [email protected] for a pdf copy of this publication.
        9. Microgravity spheroids as a reliable, long term tool for predictive toxicology. 
          S.J. Fey and K. Wrzesinski
          Toxicology Letters, 221S S153 2013. 
          DOI: 10.1016/j.toxlet.2013.05.318
        10. Determination of acute lethal and chronic lethal dose thresholds of Valproic acid using 3D spheroids constructed from the immortal human hepatocyte cell line HepG2/C3A. 
          S.J. Fey and K. Wrzesinski
          In ''Valproic Acid: Pharmacology, Mechanisms of Action and Clinical Implications'' Nova Science Publishers, New York. Ch. V, 141-165; 2013
        11. Human liver spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation.
          K. Wrzesinski, C.M. Magnone, L. Visby Hansen, M. Ehrhorn Kruse, T. Begauer, M. Bobadilla, M. Gubler, J. Mizrahi, C. M?ller Andreasen, K. Zhang, K. Eyed Joensen, S.M. Andersen and S.J. Fey
          Toxicology Research; 2(3) 163-172; 2013 
          DOI: 10.1039/C3TX20086H 
          NB: Manuscript featured on the front cover of the journal.
          View Publication (PDF)
        12. After trypsinisation, 3D spheroids of C3A hepatocytes need 18 days to re-establish similar levels of key physiological functions to those seen in the liver.
          K. Wrzesinski and S.J. Fey
          Toxicology Research; 2(2) 123-135; 2013 
          DOI: 10.1039/C2TX20060K
          NB: Manuscript featured on the front cover of the journal.
          View Publication (PDF)
        13. Determination of drug toxicity using 3D spheroids constructed from immortalized human hepatocytes. 
          S.J. Fey and K. Wrzesinski
          Toxicological Sciences 127(2) 403-411; 2012. 
          PMID: 22454432 
          DOI: 10.1093/toxsci/kfs122
          View Publication (PDF)


        <button id="eiezk"><video id="eiezk"></video></button>
            <fieldset id="eiezk"></fieldset>
            <acronym id="eiezk"><small id="eiezk"></small></acronym>
          1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
            <acronym id="eiezk"><address id="eiezk"></address></acronym>
              <source id="eiezk"><pre id="eiezk"></pre></source>

              翔田千里毛片,北条麻妃肉色开裆丝袜,欧美国产日韩一区二区在线观看 | 97在线超碰,欧美A片在线播放,大黑鸡吧操逼 | 香蕉看片,桃乃木香奈被下药侵犯,日韩黄视频 | 成人无码免费在线观看,一级操逼片,99色播 | 欧美成人www,色戒未删减版在线观看免费播放,DHDHDH18-19XXXX 黄色三级在线观看,看黄视频免费,日本美穴 | 国产热re99久久6国产精品,色姑娘av,日韩精品一区二区三区中文在线 | 一级日韩,佐佐木明希奶水喷出在线视频,久久成人人妻 | 在线一区视频,国产人伦视频,中文字幕一区二区三区伦理影院 | 日韩欧美性爱视频,伸进胸罩揉捏丰满白嫩的双乳小说,精品国产AⅤ一区二区三区4区 | 国产婬语对白在线视频露脸,飞机上疯狂做爰2电影,中文字幕+乱码+中文乱码91 |